Table 4.
Patient Symptoms by Vitamin D Levels (pg/L)a
| <30 ng/mL (N=547) | ≥30 ng/mL (N=1595) | Total (N=2142) | P value | |
|---|---|---|---|---|
| Fatigue | .045 | |||
| N | 469 (85.7%) | 1308 (82.0%) | 1777 (83.0%) | |
| Y | 78 (14.3%) | 287 (18.0%) | 365 (17.0%) | |
| Confusion | .24 | |||
| N | 547 (100.0%) | 1591 (99.7%) | 2138 (99.8%) | |
| Y | 0 (0.0%) | 4 (0.3%) | 4 (0.2%) | |
| Memory loss | .96 | |||
| N | 521 (95.2%) | 1520 (95.3%) | 2041 (95.3%) | |
| Y | 26 (4.8%) | 75 (4.7%) | 101 (4.7%) | |
| Brain fog | .68 | |||
| N | 522 (95.4%) | 1515 (95.0%) | 2037 (95.1%) | |
| Y | 25 (4.6%) | 80 (5.0%) | 105 (4.9%) | |
| Cognitive impairment | .47 | |||
| N | 529 (96.7%) | 1552 (97.3%) | 2081 (97.2%) | |
| Y | 18 (3.3%) | 43 (2.7%) | 61 (2.8%) | |
| Paresthesia | .029 | |||
| N | 528 (96.5%) | 1501 (94.1%) | 2029 (94.7%) | |
| Y | 19 (3.5%) | 94 (5.9%) | 113 (5.3%) | |
| Tingling | .066 | |||
| N | 542 (99.1%) | 1561 (97.9%) | 2103 (98.2%) | |
| Y | 5 (0.9%) | 34 (2.1%) | 39 (1.8%) | |
| Numbness | .22 | |||
| N | 531 (97.1%) | 1530 (95.9%) | 2061 (96.2%) | |
| Y | 16 (2.9%) | 65 (4.1%) | 81 (3.8%) | |
| Neuropathy | .63 | |||
| N | 523 (95.6%) | 1517 (95.1%) | 2040 (95.2%) | |
| Y | 24 (4.4%) | 78 (4.9%) | 102 (4.8%) |
a
N= no; Y = yes.